Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 13/08/18 → 12/08/19 |
Funding
- MRC: £71,250.00
Reverse engineering isogenic tumour organoids to accelerate drug discovery In liver cancer
- Boulter, Luke (Principal Investigator)
- Boulter, Luke (Co-investigator)